Pupa

Used Nuclear Fuel Recycling Agreement Signed by Orano and SHINE Technologies

Retrieved on: 
Thursday, February 29, 2024

BETHESDA, Md., Feb. 29, 2024 /PRNewswire/ -- Orano and SHINE Technologies signed a Memorandum of Understanding (MOU) this week to cooperate in the development of a U.S. pilot plant with commercial-scale technology for recycling used nuclear fuel from light water reactors.

Key Points: 
  • BETHESDA, Md., Feb. 29, 2024 /PRNewswire/ -- Orano and SHINE Technologies signed a Memorandum of Understanding (MOU) this week to cooperate in the development of a U.S. pilot plant with commercial-scale technology for recycling used nuclear fuel from light water reactors.
  • "For this initiative with SHINE, we bring more than 55 years of experience transporting and recycling used nuclear fuel in France and managing used fuel in the U.S."
    "Our goal is to stand up an operational pilot facility by the early 2030s.
  • "It is time for the U.S. to seriously consider recycling used nuclear fuel," said Jean-Luc Palayer, CEO of Orano USA.
  • Recycling used nuclear fuel into useful products will significantly reduce the mass, volume, and toxicity of the remaining nuclear material for permanent disposal.

Chrysalis Receives FDA Approval to Initiate Clinical Trials with Chrysalin™ (TP508)

Retrieved on: 
Tuesday, September 26, 2023

Chrysalis BioTherapeutics, Inc. announced today that the US Food and Drug Administration (FDA) has given the company permission to initiate human clinical trials aimed at treating acute lung failure.

Key Points: 
  • Chrysalis BioTherapeutics, Inc. announced today that the US Food and Drug Administration (FDA) has given the company permission to initiate human clinical trials aimed at treating acute lung failure.
  • Other animal studies show potential TP508 benefit in treating acute lung injury, chronic smoke inhalation, and mitigating radiation effects on brain and other tissues.
  • “TP508 is a natural regenerative peptide that accelerates tissue repair and revascularization while modulating the inflammatory response.
  • Chrysalis is using UTMB, Houston-area, and national advisors to advance TP508 for treating pulmonary indications.

SHINE Technologies Names Harrie Buurlage Chief Commercial Officer of Isotopes

Retrieved on: 
Monday, September 11, 2023

JANESVILLE, Wis., Sept. 11, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced that Harrie Buurlage has been named Chief Commercial Officer of Isotopes. Buurlage, who has been the General Manager of SHINE Europe since 2019, will now oversee all commercial aspects of SHINE's therapeutic and diagnostic medical isotope divisions. Supporting Buurlage in driving the growth of SHINE's medical isotope business will be Magdalena Brzezowska, a proven leader with extensive commercial experience in radiopharmaceuticals, who has been named Vice President of Sales and Business Development.

Key Points: 
  • JANESVILLE, Wis., Sept. 11, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced that Harrie Buurlage has been named Chief Commercial Officer of Isotopes.
  • Buurlage, who has been the General Manager of SHINE Europe since 2019, will now oversee all commercial aspects of SHINE's therapeutic and diagnostic medical isotope divisions.
  • He was the Chief Operating Officer at NRG in the Netherlands, overseeing key nuclear installations, and the global director for nuclear manufacturing at Covidien USA, now Curium Pharma.
  • "SHINE is well-positioned to provide increased access to life-saving medicine, and I look forward to helping usher in the next era of medical isotope production," Buurlage said.

SHINE Technologies Achieves Visible Proof of Fusion

Retrieved on: 
Thursday, August 3, 2023

JANESVILLE, Wis., Aug. 3, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced it has demonstrated clearly visible Cherenkov radiation produced by fusion for what is believed to be the first time in history.

Key Points: 
  • JANESVILLE, Wis., Aug. 3, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced it has demonstrated clearly visible Cherenkov radiation produced by fusion for what is believed to be the first time in history.
  • The target chamber of SHINE's fusion system is submerged underwater, allowing for the generation of visible Cherenkov radiation.
  • "The Cherenkov radiation effect produced here was bright enough to be visible, which means there's a lot of fusion happening, about 50 trillion fusions per second.
  • SHINE is industrializing and scaling fusion technology in a four-phased approach to solve important societal problems on the way to achieving safe, clean, abundant fusion energy.

SHINE Technologies Announces Opening of Largest Lutetium-177 Production Facility in North America

Retrieved on: 
Thursday, June 22, 2023

CHICAGO, June 22, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced it is opening the largest facility in North America dedicated to the production of non-carrier-added lutetium-177, a medical isotope used in targeted cancer therapies. The new facility, which will operate at SHINE's headquarters in Janesville, Wisconsin, is expected to have an initial production capacity of 100,000 doses of Lu-177 per year, with the ability to further expand production capacity to 200,000 doses per year in the future.

Key Points: 
  • CHICAGO, June 22, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced it is opening the largest facility in North America dedicated to the production of non-carrier-added lutetium-177, a medical isotope used in targeted cancer therapies.
  • SHINE continues to demonstrate its advantaged processes and production abilities and is positioned to meet the rapidly growing market.
  • Additionally, SHINE has initiated design and licensing processes for a dedicated therapeutic medical isotope production facility in Europe.
  • SHINE expects its European facility to have a similar production capacity to its U.S. facility, further bolstering its ability to meet customer needs and service the growing Lu-177 market.

EVERSANA INTOUCH Wins Five Clio Awards

Retrieved on: 
Monday, June 5, 2023

CHICAGO, June 5, 2023 /PRNewswire/ -- EVERSANA , a leading provider of commercial services to the global life sciences industry, today announced that its agency network, EVERSANA INTOUCH , has been named a five-category winner at the 2023 Clio Health Awards .

Key Points: 
  • CHICAGO, June 5, 2023 /PRNewswire/ -- EVERSANA , a leading provider of commercial services to the global life sciences industry, today announced that its agency network, EVERSANA INTOUCH , has been named a five-category winner at the 2023 Clio Health Awards .
  • The team earned one gold, one silver, and three bronze awards for work with The Chrysalis Initiative and the Global Lyme Alliance.
  • "What a tremendous achievement to be recognized across multiple categories at the Clio Awards," said Jim Lang, CEO, EVERSANA.
  • Annually, The Clio Awards bring together leading creative talent for an exclusive and collaborative judging experience to select the entries for the coveted Clio statues.

SHINE Technologies to Participate in Morgan Stanley's Sustainable Finance Summit

Retrieved on: 
Tuesday, May 23, 2023

JANESVILLE, Wis., May 23, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced that the company will participate in the Morgan Stanley Annual Sustainable Finance Summit this week in New York.

Key Points: 
  • JANESVILLE, Wis., May 23, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced that the company will participate in the Morgan Stanley Annual Sustainable Finance Summit this week in New York.
  • Todd Asmuth, president and CSO of SHINE, will hold a fireside chat, Illuminating the Path to Fusion Energy.
  • Todd Asmuth, President and Chief Strategy Officer of SHINE Technologies, will hold a fireside chat, Illuminating the Path to Fusion Energy.
  • In 2022, SHINE submitted a Drug Master File with the U.S. Food and Drug Administration for non-carrier-added lutetium-177.

Electra Officials to Receive Top AIAA Honors

Retrieved on: 
Thursday, May 18, 2023

MANASSAS, Va., May 18, 2023 /PRNewswire/ -- Electra.aero, Inc. ("Electra") is pleased to announce that the American Institute of Aeronautics and Astronautics (AIAA) has recognized key Electra principals with two of their highest awards:

Key Points: 
  • Langford to Receive 2023 AIAA Reed Aeronautics Award,
    MANASSAS, Va., May 18, 2023 /PRNewswire/ -- Electra.aero, Inc. ("Electra") is pleased to announce that the American Institute of Aeronautics and Astronautics (AIAA) has recognized key Electra principals with two of their highest awards:
    Mark Drela elected as an AIAA Class of 2023 Honorary Fellow.
  • Langford and Drela have worked together for 45 years, first collborating at the Massachusetts Institute of Technology.
  • Langford currently leads Electra as its founder and Chief Executive Officer (CEO) and was previously founder of Aurora Flight Sciences where he served as CEO from 1989-2019.
  • Drela was a key contributor to many projects at Aurora and, along with John Hansman, originated the concept for the Electra eSTOL aircraft while at MIT.

SHINE Technologies' Tracy Radel Among 40 Under 40 Honorees

Retrieved on: 
Thursday, March 16, 2023

JANESVILLE, Wis., March 16, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, is proud to announce that Tracy Radel, Vice President of Engineering, has been selected as one of In Business Madison Magazine's 40 Under 40 honorees. The annual award honors the most successful and civic-minded emerging leaders in the Greater Madison, Wisconsin area.

Key Points: 
  • JANESVILLE, Wis., March 16, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, is proud to announce that Tracy Radel, Vice President of Engineering, has been selected as one of In Business Madison Magazine's 40 Under 40 honorees.
  • In her role, Radel has been an important leader in the building of The Chrysalis, SHINE's large-scale medical isotope production facility in Janesville.
  • It was a milestone not seen with the NRC in more than 35 years, and a first-ever accomplishment for a growth-stage company like SHINE.
  • "I'm humbled and honored to be chosen by In Business as part of this year's 40 Under 40 class," Radel said.

Reservoir Celebrates De La Soul’s Catalog, Out Now on All Streaming Platforms

Retrieved on: 
Friday, March 3, 2023

This momentous release stems from Reservoir’s 2021 acquisition of legendary independent hip-hop label Tommy Boy Music.

Key Points: 
  • This momentous release stems from Reservoir’s 2021 acquisition of legendary independent hip-hop label Tommy Boy Music.
  • In addition to the digital albums, De La Soul is also releasing exclusive merchandise, vinyl, CDs, and cassettes, all distributed by Chrysalis Records, now available for purchase and pre-order on wearedelasoul.com.
  • De La Soul said, “Today is bittersweet, finally celebrating our music on streaming, but missing Dave.
  • This is a long-awaited moment for fans, and we’re honored to help cultivate a new generation of De La Soul listeners.”